Research-use agreement required
You must actively agree before entering Revalin.
All products are strictly for research purposes only and are not intended for human consumption. These products have not been evaluated or approved by the FDA or Health Canada.
You must be 21 or older to browse this site.
Optional research details
Leaving these fields blank records that no institution or research details were provided.
This is the research-use access gate, separate from cookie consent.
By clicking Yes, you confirm you are 21 or older, are acting for lawful research purposes, and agree to our Terms of Service and Privacy Policy.
Compound profile
GLP-1/GIP/Glucagon Triple Agonist
Long-acting GLP-1, GIP, and Glucagon Receptor Agonist
A synthetic long-acting peptide designed to function as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. This class of compounds is currently under investigation for its role in metabolic regulation, including glucose handling, energy balance, and hepatic lipid dynamics in controlled research environments. Preclinical and early clinical studies suggest significant effects on body composition and liver fat modulation, positioning triple agonist peptides as an emerging area of metabolic research. For laboratory research use only. Not for human consumption.
Sequence
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{Lys(AEEA-γ-Glu-C20 diacid)}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-
Molecular weight
~4,859.60g/mol
CAS
—
